Effectiveness and safety of programmed cell death-1 inhibitor in the treatment of advanced non-HBV non-HCV-related hepatocellular carcinoma

LIU Haonan, WU Meng, LU Tong, HAN Zhengxiang - 临床肝胆病杂志, 2022 - lcgdbzz.org
Objective To investigate the clinical effectiveness and adverse events of domestic
programmed cell death-1 (PD-1) inhibitor in the treatment of advanced non-HBV non-HCV …
相关文章

Effectiveness and safety of programmed cell death-1 inhibitor in the treatment of advanced non-HBV non-HCV-related hepatocellular carcinoma

LIU Haonan, W Yuqin, WU Meng, LU Tong, Z Yang… - 临床肝胆病杂志, 2022 - lcgdbzz.com
Objective To investigate the clinical effectiveness and adverse events of domestic
programmed cell death-1 (PD-1) inhibitor in the treatment of advanced non-HBV non-HCV …